Silo Pharma jumps on U.S. patent for anxiety drug

Silo Pharma

02/02/2023 18:44

** Shares of drug developer Silo Pharma Inc  SILO.O  jump
14.8% to $3.02
    ** Stock set for its biggest one-day pct gain in over a
month, if gains hold
    ** Co says it has been granted U.S. patent for its
experimental drug to prevent and treat stress-induced disorders
including anxiety and post-traumatic stress disorder
    ** The patent covers the use of the drug candidate, SPC-15,
in a method of treating stress-induced disorders -SILO
    ** Co had entered into a sponsored research agreement with
Columbia University to develop SPC-15 for stress-induced
disorders         
    ** Including session moves, stock down ~70.5% over the past
12 months
 (Reporting by Mariam E Sunny)
 ((Mariam.ESunny@thomsonreuters.com;))